Literature DB >> 14636246

Naive T cells are maintained by thymic output in early ages but by proliferation without phenotypic change after age twenty.

John M Murray1, Gilbert R Kaufmann, Philip D Hodgkin, Sharon R Lewin, Anthony D Kelleher, Miles P Davenport, John J Zaunders.   

Abstract

Analysing T-cell receptor excision circle numbers in healthy individuals we find a marked change in the source of naive T cells before and after 20 years of age. The bulk of the naive T cell pool is sustained primarily from thymic output for individuals younger than 20 years of age whereas proliferation within the naive phenotype is dominant for older individuals. Over 90% of phenotypically naive T cells in middle age are not of direct thymic origin. Moreover, this change in source of naive T cells is accompanied either by an increased death rate of T cells from the thymus or reduced thymic export. Modelling of these processes shows that new naive T cells of a thymic origin have a half-life of approximately 50 days before this change occurs, and that either the life-span of recent thymic emigrants (but not necessarily of all naive cells) decreases approximately threefold in middle age, or thymic production drops by this same amount. The decay rate of T-cell receptor excision circle levels for individuals over 20 years of age is consistent with the decay rate of the productive thymus. Our modelling suggests that at age 25, thymic export is responsible for 20% of naive T-cell production and that this percentage decreases with the 15.7 year half-life of the productive thymus so that by age 55 only 5% of naive production arises from thymic export.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14636246     DOI: 10.1046/j.1440-1711.2003.01191.x

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  42 in total

Review 1.  Reversing T cell immunosenescence: why, who, and how.

Authors:  Pierre Olivier Lang; Sheila Govind; Richard Aspinall
Journal:  Age (Dordr)       Date:  2012-02-26

2.  Low thymic output in the 22q11.2 deletion syndrome measured by CCR9+CD45RA+ T cell counts and T cell receptor rearrangement excision circles.

Authors:  K Lima; T G Abrahamsen; I Foelling; S Natvig; L P Ryder; R W Olaussen
Journal:  Clin Exp Immunol       Date:  2010-05-10       Impact factor: 4.330

3.  Altered naive CD4 and CD8 T cell homeostasis in patients with relapsing-remitting multiple sclerosis: thymic versus peripheral (non-thymic) mechanisms.

Authors:  D A Duszczyszyn; J D Beck; J Antel; A Bar-Or; Y Lapierre; V Gadag; D G Haegert
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

Review 4.  Immunotherapy in Older Adults with Cancer.

Authors:  Richard Curtis Godby; Douglas B Johnson; Grant R Williams
Journal:  Curr Oncol Rep       Date:  2019-05-07       Impact factor: 5.075

Review 5.  Immunosenescence: the Role of Aging in the Predisposition to Neuro-Infectious Complications Arising from the Treatment of Multiple Sclerosis.

Authors:  Elena Grebenciucova; Joseph R Berger
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08       Impact factor: 5.081

Review 6.  Thymus: the next (re)generation.

Authors:  Mohammed S Chaudhry; Enrico Velardi; Jarrod A Dudakov; Marcel R M van den Brink
Journal:  Immunol Rev       Date:  2016-05       Impact factor: 12.988

7.  Imaging of Programmed Cell Death Ligand 1: Impact of Protein Concentration on Distribution of Anti-PD-L1 SPECT Agents in an Immunocompetent Murine Model of Melanoma.

Authors:  Jessie R Nedrow; Anders Josefsson; Sunju Park; Sagar Ranka; Sanchita Roy; George Sgouros
Journal:  J Nucl Med       Date:  2017-05-18       Impact factor: 10.057

8.  In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy.

Authors:  Tanya Lynn Applegate; Donald John Birkett; Glen John Mcintyre; Angel Belisario Jaramillo; Geoff Symonds; John Michael Murray
Journal:  Retrovirology       Date:  2010-10-09       Impact factor: 4.602

9.  Modelling experimental uveitis: barrier effects in autoimmune disease.

Authors:  David Nicholson; Emma C Kerr; Owen G Jepps; Lindsay B Nicholson
Journal:  Inflamm Res       Date:  2012-04-10       Impact factor: 4.575

10.  Bayesian immunological model development from the literature: example investigation of recent thymic emigrants.

Authors:  Tyson H Holmes; David B Lewis
Journal:  J Immunol Methods       Date:  2014-08-29       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.